Literature DB >> 1878351

Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells.

R S Herbst1, U Nielsch, F Sladek, E Lai, L E Babiss, J E Darnell.   

Abstract

To investigate the regulation of genes whose expression is enriched in liver we studied expression of the albumin and transthyretin (TTR) genes in a series of rat hepatoma cell lines (FaO, C2, C2rev7, and H5) that express these genes at different rates. The level of expression of albumin and TTR was compared to the expression and DNA-binding activity of four transcription factors, HNF1/LFB1, C/EBP, HNF3, and HNF4, that are found at high concentrations in liver. We conclude that the levels of these factors are controlled both transcriptionally (HNF-3, HNF-4, and C/EBP) and post-transcriptionally (HNF-1/LFB1), and that the cellular concentration of these DNA-binding proteins helps explain the level of transcriptional activity observed for the genes they regulate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1878351

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  15 in total

1.  Liver-enriched transcription factors uncoupled from expression of hepatic functions in hepatoma cell lines.

Authors:  D Chaya; C Fougère-Deschatrette; M C Weiss
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

2.  The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.

Authors:  Xin Wang; Francesca Cattaneo; Lisa Ryno; John Hulleman; Natàlia Reixach; Joel N Buxbaum
Journal:  J Neurosci       Date:  2014-05-21       Impact factor: 6.167

3.  A specific distal promoter controls gamma-glutamyl transpeptidase gene expression in undifferentiated rat transformed liver cells.

Authors:  S Nomura; O Lahuna; T Suzuki; A Brouillet; M N Chobert; Y Laperche
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

4.  Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer.

Authors:  Christina Vorvis; Maria Hatziapostolou; Swapna Mahurkar-Joshi; Marina Koutsioumpa; Jennifer Williams; Timothy R Donahue; George A Poultsides; Guido Eibl; Dimitrios Iliopoulos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-05       Impact factor: 4.052

5.  Differentiation-inducing activity of hydroxycamptothecin on cancer stem-like cells derived from hepatocellular carcinoma.

Authors:  Yi Zhang; Wen-Jie Song; Fu-Qin Zhang; Wei-Hui Liu; Ke-Feng Dou
Journal:  Dig Dis Sci       Date:  2011-02-12       Impact factor: 3.199

6.  HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures.

Authors:  George K Michalopoulos; William C Bowen; Karen Mulè; Jianhua Luo
Journal:  Gene Expr       Date:  2003

7.  High level activity of the mouse CCAAT/enhancer binding protein (C/EBP alpha) gene promoter involves autoregulation and several ubiquitous transcription factors.

Authors:  C Legraverend; P Antonson; P Flodby; K G Xanthopoulos
Journal:  Nucleic Acids Res       Date:  1993-04-25       Impact factor: 16.971

8.  Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma.

Authors:  Hai Song; Shuang-Luo Xia; Cheng Liao; Yi-Liang Li; Yi-Fei Wang; Tsai-Ping Li; Mu-Jun Zhao
Journal:  World J Gastroenterol       Date:  2004-02-15       Impact factor: 5.742

9.  Participation of Ets transcription factors in the glucocorticoid response of the rat tyrosine aminotransferase gene.

Authors:  M L Espinás; J Roux; J Ghysdael; R Pictet; T Grange
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

10.  Liver-specific expression of human insulin-like growth factor binding protein 1: functional role of transcription factor HNF1 in vivo.

Authors:  S Babajko; F Tronche; A Groyer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.